Navigation
banner

Diabetes Drug Discovery & Development

2017-11-212018-03-092018-02-09
EARLY BIRD DISCOUNT! Register by Feb 09, 2018 to receive 20% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!


registration button

Subscribe for updates




Dear Colleague,

The 11th Diabetes Drug Discovery & Development Conference is part of GTCbio’s Diabetes Summit which encompasses the drug discovery and partnering aspects of diabetes in three tracks. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, and round-table discussions that highlight basic research novel therapeutic targets, translation to the clinic, and other relevant topics.

Joint Plenary Sessions:

  1. Opening Keynote Session – Historical Perspective & Current State of the Industry
  2. Round Table Discussions
  3. Ready, Set, Grow – New Company/Technology Pitch Competition & Lunch
  4. Award Ceremony & Closing Keynote Session – Predictions for future

Diabetes Drug Discovery & Development:

  1. What’s New in Type I Diabetes – Targets, Models, Assays, etc.
  2. Translational and Clinical Development for Type I Diabetes
  3. What’s New in Type II Diabetes – Targets, Models, Assays, etc.
  4. Translational and Clinical Development for Type II Diabetes

 

This conference is part of the Diabetes Summit taking place April 2018 in Boston, MA which includes three conferences:

Track 1: 11th Diabetes Drug Discovery & Development Conference
Track 2: 8th Diabetes Partnering & Deal-Making Conference
Track 3: Devices and Digital Aids in Diabetes Management Conference

 

Best regards,

The 2018 Advisory Committee

2017 Advisory Board Members
Robert Geho, Diasome Pharmaceuticals Inc
Zan Fleming, Kinexum
Alan Cherrington, Vanderbilt
Nirja Patel, ALPCO Diagnostics
Vivek Shenoy, Renovo